Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus

OBJECTIVES: To assess glucagon-like peptide 1 (GLP-1) secretion after oral glucose tolerance tests (OGTTs) in subjects with newly diagnosed type 2 diabetes mellitus (T2DM), impaired glucose tolerance (IGT), and normal glucose tolerance (NGT) to clarify changes in GLP-1 secretion during the course of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Saudi Med J
Auteurs principaux: Wang, Xiao-Li, Ye, Fang, Li, Jun, Zhu, Ling-Yun, Feng, Gang, Chang, Xiang-Yun, Sun, Kan
Format: Artigo
Langue:Inglês
Publié: Saudi Medical Journal 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4724679/
https://ncbi.nlm.nih.gov/pubmed/26739974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15537/smj.2016.1.12035
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires